Insider · CIK 0001516354

Roberts Brandi

Reports to the SEC for 6 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001516354

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	DFTXDefinium Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,377 sh	$36.57	−$123K	394,528
2026-09-14	DFTXDefinium Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+125K sh	—	—	397,905
2026-08-12	DFTXDefinium Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+62.5K sh	—	—	271,987
2026-06-25	DFTXDefinium Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,013 sh	$45.03	−$136K	209,487
2026-06-22	DFTXDefinium Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+62.5K sh	—	—	212,500
2026-02-03	DFTXDefinium Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2025-06-02	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+500K sh	—	—	500,000
2024-12-02	Longboard Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Executive VP and CFO	DDisposition to Issuer	−15.1K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Executive VP and CFO	DDisposition to Issuer	−7,900 sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CFO	DDisposition to Issuer	−120K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CFO	DDisposition to Issuer	−90K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CFO	DDisposition to Issuer	−139K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CFO	DDisposition to Issuer	−90.6K sh	—	—	0
2024-10-25	Longboard Pharmaceuticals, Inc.Retention Restricted Stock UnitsA Award	Executive VP and CFO	AAward	+7,900 sh	—	—	7,900
2024-07-03	TFF Pharmaceuticals, Inc.A Award	Director	AAward	+3,165 sh	—	—	23,165
2024-07-03	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+3,165 sh	—	—	3,165
2024-04-18	TFF Pharmaceuticals, Inc.Restricted stock unitsA Award	Director	AAward	+5,333 sh	—	—	5,333
2024-02-08	Longboard Pharmaceuticals, Inc.A Award	Executive VP and CFO	AAward	+15.1K sh	—	—	15,090
2024-02-08	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Executive VP and CFO	AAward	+90.6K sh	—	—	90,580
2023-12-01	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+52.9K sh	—	—	52,858
2023-08-15	TFF Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+20K sh	$0.25	+$5,000	20,000
2023-02-09	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Executive VP and CFO	AAward	+120K sh	—	—	119,700
2022-12-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+21K sh	—	—	20,968
2022-02-09	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Executive VP and CFO	AAward	+90K sh	—	—	90,000
2020-03-17	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	CFO & SVP Finance	AAward	+617K sh	—	—	616,700
2019-08-13	LCTXLineage Cell Therapeutics, Inc.P Purchase	CFO & SVP Finance	PPurchase	+5,000 sh	$1.01	+$5,050	5,000
2019-06-30	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	CFO & SVP Finance	AAward	+150K sh	—	—	150,000
2019-01-07	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	CFO & SVP Finance	AAward	+500K sh	—	—	500,000
2018-06-29	REVA Medical, Inc.P Purchase	SVP & Chief Financial Officer	PPurchase	+4,907.9 sh	$1.53	+$7,509.087	54,907.9
2018-01-22	REVA Medical, Inc.Employee Stock Option (right to buy)A Award	SVP & Chief Financial Officer	AAward	+100K sh	—	—	100,000
2018-01-22	REVA Medical, Inc.A Award	SVP & Chief Financial Officer	AAward	+50K sh	—	—	50,000
2017-09-18	REVA Medical, Inc.Employee Stock Option (right to buy)A Award	SVP & Chief Financial Officer	AAward	+190K sh	—	—	190,000
2017-01-20	SVRASavara Inc · Restricted Stock UnitsA Award	Chief Financial Officer & SVP	AAward	+890K sh	—	—	889,926
2016-01-04	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+573K sh	—	—	572,700
2015-06-11	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+444K sh	—	—	444,400
2015-03-27	SVRASavara IncP Purchase	Chief Financial Officer & SVP	PPurchase	+18K sh	$0.50	+$8,949.6	38,000
2015-03-26	SVRASavara IncP Purchase	Chief Financial Officer & SVP	PPurchase	+20K sh	$0.50	+$10K	20,000
2015-01-02	SVRASavara Inc · Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+723K sh	—	—	722,800
2014-01-02	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+101K sh	—	—	101,200
2013-06-19	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+301K sh	—	—	301,250
2013-01-02	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+75.8K sh	—	—	75,750
2011-12-08	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+140K sh	—	—	140,000
2011-06-15	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+85K sh	—	—	85,000

Recent filings

Accepted (ET)
Sep 294
Roberts Brandi0001104659-26-112058
SEC(opens sec.gov)
Sep 144
Roberts Brandi0001193125-26-389888
SEC(opens sec.gov)
Aug 124
Roberts Brandi0001193125-26-345835
SEC(opens sec.gov)
Jun 264
Roberts Brandi0001193125-26-285563
SEC(opens sec.gov)
Jun 224
Roberts Brandi0001193125-26-276880
SEC(opens sec.gov)
Feb 54
Roberts Brandi0001193125-26-039585
SEC(opens sec.gov)
Jun 24
Roberts Brandi0000950170-25-080407
SEC(opens sec.gov)
Dec 24
Roberts Brandi0001415889-24-028022
SEC(opens sec.gov)
Oct 294
Roberts Brandi0000950170-24-118312
SEC(opens sec.gov)
Jul 84
Roberts Brandi0001213900-24-059875
SEC(opens sec.gov)
Apr 224
Roberts Brandi0001213900-24-035081
SEC(opens sec.gov)
Feb 94
Roberts Brandi0001209191-24-003026
SEC(opens sec.gov)
Dec 44
Roberts Brandi0001213900-23-092826
SEC(opens sec.gov)

Companies

Address

C/O DEFINIUM THERAPEUTICS, INC. ONE WORLD TRADE CENTER, SUITE 8500

NEW YORK, NY, 10007